Alumni - Current Positions

If you are an alumnus and your information is not up to date, please contact Aileen Rosales at  (212) 746-6250 to provide us with your current information.   

(updated 03/2025)

Name Year of Graduation Advisor's Name Thesis Project Current Position
Christina Bebernitz 2021 Renier Brentjens

IL-12 and IL-18 Combination Improves Activation of Adoptively Transferred T cells in Solid Tumors

Biotech Research Analyst at First Light Asset Management

Karen Chu 2021 Kharas/Leslie

Identifying the MUSASHI-2 Network and its Functional Impact in Normal and Malignant Blood

TBA

Megan Dacek 2021 David Scheinberg

Potentiating Innate Immunity with Engineered CAR T Cells

Associate Constultant - The Dedham Group

Faith Fowler 2021 Jessica Tyler

The Regulation of DNA End Resection at DNA Double Strand Breaks

Scientist - Calico Life Sciences 
Jaclyn Kubala 2021 Lorraine Gudas/Daniel Heller

The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma

Scientist II, SalioGen Therapeutics

Rachel Langenbacher 2021 Daniel Heller

In Situ Hybridization Nanoprobes to Investigate Mu Opioid Receptor Alternative Splicing

Associate medical writer - PPD
George Liao 2021 Yueming Li

The Role of γ-Glutamyltransferase1 in the Regulation of γ-Secretase Activity in the Healthy and Diseased Kidney

Healthcare Investor at CBC Group

Veronica Nagle 2021 Jason Lewis/Ingo Mellinghoff

Brain Tumor Imaging

Engagement Manager at Lumanity

Pengju Nie 2021 Dr. Yueming Li

Development of Chemical Probes for Cancer and Neurodegenerative Diseases: From Imaging to Mechanistic Insights 

Postdoctoral Associate, Yale University

Chanel Richardson 2021 Robert Schwartz

The Role of Induced Pluripotent Stem Cell Hepatocyte Like Cells in Understanding Liver Biology

Investment Banking Associate at Morgan Stanley
Lisa Standke 2021 Derek Tan

Development of Pharmacologically Optimized Inhibitors of M. tuberculosis MbtA as Novel Antibioticsby 

Science Writer | Research, Writing, Science Communication

Evan Stater 2021 Jan Grimm

Improving the Response of a Treatment-refractory Cancer to Monoclonal Antibody Immunotherapy by Nanodelivery of an Immunostimulatory Adjunct Drug 

Postdoctoral Scientist at Memorial Sloan Kettering Cancer Center

Colin Tang 2021 Ingo Mellinghoff

Paradoxical GCN2 Kinase Activation Enhances Antitumor Activity of Kinase Inhibitors

Research Scientist at Vevo Therapeutics

Kathyrn Tully 2021 Jason Lewis

"Radioimmunotherapy and ImmunoPET Imaging Targeting Delta-like Ligand 3 in Small Cell Lung Cancer"

Scientist at Ratio Therapeutics

Corrin Wohlhieter 2021 Charles Rudin

Senior Associate at Clarion | A Life Sciences Consultancy

Senior Manager, Oncology CI at BMS